The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals.
about
Preparative purification of recombinant proteins: current status and future trendsTherapeutic applications of extracellular vesicles: clinical promise and open questions.Adapting viral safety assurance strategies to continuous processing of biological products.Characterization of operating parameters for XMuLV inactivation by low pH treatment.Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation.A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity.Cation exchange chromatography provides effective retrovirus clearance for antibody purification processes.
P2860
Q27008176-22FB64D3-1648-4128-81C8-748C37D3E9BBQ35654719-7BDB4587-5684-4364-9874-5A21E7F33A45Q38913337-F500EAE0-9D7B-4838-AFCC-DDE24F890D80Q40406903-485FA82A-B6AB-46AE-A233-DC67CC709033Q40500491-32A0826C-1406-42B5-8BDE-A8F1D66AACC6Q45398057-636C938D-8C80-4D0A-B5C6-A36991EB2FFBQ51766021-BF14E7A9-BDE4-4324-80A8-449BC55B77BB
P2860
The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The clearance of viruses and t ...... pathy agents from biologicals.
@ast
The clearance of viruses and t ...... pathy agents from biologicals.
@en
type
label
The clearance of viruses and t ...... pathy agents from biologicals.
@ast
The clearance of viruses and t ...... pathy agents from biologicals.
@en
prefLabel
The clearance of viruses and t ...... pathy agents from biologicals.
@ast
The clearance of viruses and t ...... pathy agents from biologicals.
@en
P2093
P1476
The clearance of viruses and t ...... pathy agents from biologicals.
@en
P2093
David M Asher
Dorothy Scott
Kurt Brorson
Mahmood Farshid
Rolf E Taffs
P304
P356
10.1016/J.COPBIO.2005.07.006
P577
2005-10-01T00:00:00Z